Table 2 Within group analysis before and after the intervention

^aFPG(mg/dl)

Pre

32

166

43.03

0.51

25

169.5

62.78

0.6

30

183.58

72.16

0.9

Post

32

159.5

44.08

25

163.54

69.72

30

181.84

71.77

^bHb A1C% Pre (mmol/mol)

32

9.6

(82)

1.62

0.39

25

9.3

(78)

1.6

0.15

30

9.4

(79)

1.71

0.5

Post

32

9.4

(79)

1.54

25

9.8

(84)

2.26

30

9.6

(81)

1.94

Adherence

Pre

30

5.55

1.88

0.1

21

5.42

1.67

0.58

29

5.03

1.79

0.02

Post

30

6.07

1.49

21

5.61

1.96

29

5.75

1.49

Systolic^c BP(mmHg) Pre

32

133.81

20.91

0.02

26

127.07

19

0.55

30

126.06

16.17

0.34

Post

32

127.75

18.62

26

129.46

19.21

30

129.26

17.91

DiastolicBP(mmHg) Pre

32

84.25

11.74

0.07

26

81.84

9.39

0.66

30

80.2

7.34

0.06

Post

32

81.12

9.18

26

81

10.6

30

83.3

8.5

Total Cholesterol(mg/dl) Pre

32

218.87

48.81

0.34

25

233.19

40.93

0.32

30

211.37

36.42

0.09

Post

32

225.13

44.76

25

228.24

35.82

30

227.2

55.59

Waist Hip Ratio Pre

32

0.96

0.045

0.34

27

0.97

0.04

0.02

30

0.98

0.051

0.002

Post

32

0.95

0.053

27

0.94

0.04

30

0.94

0.054

Body Mass Index (kg/m²) Pre

32

24.74

3.97

0.09

31

25.54

4.52

0.05

35

24.86

4.07

0.01

Post

32

22.82

7.16

31

21.72

9.36

35

20.32

10.06